Corcept Therapeutics and Twist Bioscience are noted as holdings within the First Trust biotech fund.
1 report, 1 independent
Updated Aug 19
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Corcept Therapeutics and Twist Bioscience are noted as holdings within the First Trust biotech fund.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Corcept Therapeutics
American pharmaceutical company
-
Twist Bioscience
Biotechnology company
Related events
- Investor activity regarding Corcept Therapeutics, including RBC boosting holdings and Amundi buying, was disclosed via SEC filings.
- Celcuity Inc. and Corcept Therapeutics are noted for developing targeted therapies in the United States.
- Corcept Therapeutics is seeking final approval from the European Commission for a cancer therapy already approved in the US market.